AVEO Oncology
AVEO
#7323
Rank
โ‚ฌ0.47 B
Marketcap
13,67ย โ‚ฌ
Share price
0.00%
Change (1 day)
184.73%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -โ‚ฌ26.9 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are โ‚ฌ94.31 Million. In 2021 the company made an earning of -โ‚ฌ48.61 Million a decrease over its 2020 earnings that were of -โ‚ฌ32.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ26.9 Million-44.67%
2021 -โ‚ฌ48.61 Million49.9%
2020 -โ‚ฌ32.43 Million-479.04%
2019 โ‚ฌ8.55 M-276.17%
2018 -โ‚ฌ4.86 Million-91.79%
2017 -โ‚ฌ59.16 Million142.38%
2016 -โ‚ฌ24.41 Million78.51%
2015 -โ‚ฌ13.68 Million-71.55%
2014 -โ‚ฌ48.06 Million-50.72%
2013 -โ‚ฌ97.53 Million-4.88%
2012 -โ‚ฌ0.11 Billion-426.29%
2011 โ‚ฌ31.42 M-159.85%
2010 -โ‚ฌ52.51 Million35.33%
2009 -โ‚ฌ38.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ31.68 B-119,832.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.07 B-38,159.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ0.40 B-1,632.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ5.18 B-19,683.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.32 B-39,123.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-โ‚ฌ2.06 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA